Amphastar Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Amphastar Pharmaceuticals's balance sheet done over the years? Its assets were worth $1,512,912,000 last year, which is more than in the previous period. 58% of Amphastar Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $873,491,000, which means an increase by 309% compared compared to last year.
Debt to Assets
| 2014 | 389370000 | 107.51M | 27.61% |
|---|---|---|---|
| 2015 | 390136000 | 94.62M | 24.25% |
| 2016 | 427738000 | 98.48M | 23.02% |
| 2017 | 454665000 | 117.33M | 25.81% |
| 2018 | 513563000 | 149.20M | 29.05% |
| 2019 | 586971000 | 159.44M | 27.16% |
| 2020 | 631236000 | 182.51M | 28.91% |
| 2021 | 671529000 | 226.00M | 33.66% |
| 2022 | 741987000 | 213.32M | 28.75% |
| 2023 | 1512912000 | 873.49M | 57.74% |
AMPH Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 144.29M | 156.09M | 126.35M | 92.64M | 73.68M | 86.33M | 65.59M | 72.35M | 66.07M | 67.82M |
Short term investments | 112.51M | 19.66M | 10.32M | 12.97M | 11.67M | 2.83M | 2.63M | 527K | 1.28M | 1.49M |
Net receivables | 114.94M | 88.97M | 78.93M | 66.39M | 45.68M | 52.21M | 35.99M | 26.79M | 33.23M | 22.85M |
Inventory | 105.83M | 103.58M | 92.80M | 96.83M | 110.50M | 69.32M | 63.60M | 79.75M | 70.66M | 82.33M |
Other current assets | 12.01M | 7.56M | 7.27M | 6.77M | 9.53M | 5.48M | 19.94M | 3.27M | 5.96M | 24.98M |
Total current assets | 489.6M | 378.31M | 318.11M | 279.68M | 255.24M | 220.34M | 187.77M | 184.09M | 175.93M | 197.99M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 315.64M | 264.57M | 271.49M | 280.70M | 253.54M | 210.41M | 185.33M | 152.94M | 142.16M | 138.28M |
Goodwill | 3.21M | 3.12M | 3.31M | 3.94M | 3.63M | 3.95M | 4.46M | 3.97M | 3.72M | 4.46M |
Intangible assets | 610.07M | 34.17M | 35.55M | 36.67M | 37.51M | 38.31M | 40.67M | 46.33M | 36.17M | 38.09M |
Long term investments | 15.21M | 2.41M | 3.98M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 25.91M | 20.85M | 16.66M | 5.25M | 11.15M | 9.91M | 8.66M | 9.39M | 4.69M | 3.58M |
Total non-current assets | 1.02B | 363.66M | 353.41M | 351.55M | 331.73M | 293.22M | 266.88M | 243.64M | 214.20M | 191.37M |
Total assets | 1.51B | 741.98M | 671.52M | 631.23M | 586.97M | 513.56M | 454.66M | 427.73M | 390.13M | 389.37M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 0 | -56.09M | 0 | 97K | 643K | 14.01M |
Short term debt | 8.24M | 6.04M | 5.18M | 15.62M | 10.91M | 18.22M | 6.31M | 5.36M | 10.93M | 7.59M |
Total current liabilities | 225.40M | 94.86M | 103.81M | 112.20M | 90.00M | 106.83M | 67.19M | 60.61M | 59.95M | 62.59M |
| Non-current liabilities: | ||||||||||
Long term debt | 619.3M | 96.53M | 99.47M | 51.65M | 55.70M | 31.98M | 40.84M | 32.35M | 30.16M | 36.10M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 28.78M | 14.56M | 15.65M | 13.21M | 9.43M | 8.94M | 7.93M | 3.11M | 3.16M | 5.63M |
Total non-current liabilities | 648.08M | 118.46M | 122.19M | 70.31M | 69.43M | 42.37M | 50.14M | 37.86M | 34.67M | 44.91M |
Total liabilities | 873.49M | 213.32M | 226.00M | 182.51M | 159.44M | 149.20M | 117.33M | 98.48M | 94.62M | 107.51M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |